A synthetic GHRH analog studied for growth hormone secretion support and sleep quality. Physician-reviewed. Prescription required.
Sermorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH). It stimulates the pituitary gland to produce and secrete growth hormone naturally, preserving the normal pulsatile release pattern. Unlike synthetic HGH, sermorelin works through the body's own feedback mechanisms.
Sermorelin protocols have been studied for GH axis stimulation and sleep quality improvement. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.
| Mechanism | Biological Effect |
|---|---|
| GHRH receptor agonist | Stimulates pituitary GH release in natural pulsatile pattern |
| GH/IGF-1 axis activation | May influence anabolic signaling pathways |
| Sleep architecture support | GH pulses during deep sleep; improves sleep quality |
| Lipolysis enhancement | May influence metabolic signaling |
| Collagen synthesis | Connective tissue repair, joint and skin support |
| Tissue signaling | GH-mediated tissue signaling studied in clinical settings |
Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with NAD+ candidates:
Individuals with documented or suspected GH decline seeking physician-supervised sermorelin support.
Individuals seeking physician-supervised GH axis evaluation.
Individuals seeking physician-reviewed GH secretagogue therapy under clinical supervision.
Individuals experiencing disrupted sleep, low energy, or poor recovery who may benefit from GH pulse support.
All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.
Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD
Valid prescription — Issued by your attending physician upon protocol approval
Pharmacy-dispensed compound — From our licensed 503A compounding pharmacy partner
Follow-up check-in — Physician review at protocol midpoint; reorder pathway established
Your physician will review your complete health history before determining eligibility.